Drug-resistant hypertensive patients may be treated by mechanical stimulation of stretchsensitive baroreceptors located in the sinus of carotid arteries. To evaluate the efficacy of endovascular devices to stretch the carotid sinus such that the induced strain might trigger baroreceptors to increase action potential firing rate and thereby reduce systemic blood pressure, numerical simulations were conducted of devices deployed in subjectspecific carotid models. Two models were chosen-a typical physiologic carotid and a diminutive atypical physiologic model representing a clinically worst case scenario-to evaluate the effects of device deployment in normal and extreme cases, respectively. Based on the anatomical dimensions of the carotids, two different device sizes were chosen out of five total device sizes available. A fluid structure interaction (FSI) simulation methodology with contact surface between the device and the arterial wall was implemented for resolving the stresses and strains induced by device deployment. Results indicate that device deployment in the carotid sinus of the physiologic model induces an increase of 2.5% and 7.5% in circumferential and longitudinal wall stretch, respectively, and a maximum of 54% increase in von Mises arterial stress at the sinus wall baroreceptor region. The second device, deployed in the diminutive carotid model, induces an increase of 6% in both circumferential and longitudinal stretch and a 50% maximum increase in von Mises stress at the sinus wall baroreceptor region. Device deployment has a minimal effect on blood-flow patterns, indicating that it does not adversely affect carotid bifurcation hemodynamics in the physiologic model. In the smaller carotid model, deployment of the device lowers wall shear stress at sinus by 16% while accelerating flow entering the external carotid artery branch. Our FSI simulations of carotid arteries with deployed device show that the device induces localized increase in wall stretch at the sinus, suggesting that this will activate baroreceptors and subsequently may control hypertension in drug-resistant hypertensive patients, with no consequential deleterious effects on the carotid sinus hemodynamics.
Introduction
Hypertension is the chronic condition of elevated blood pressure contributing to severe cardiovascular pathologies, such as stroke, heart attacks, arterial aneurysms, renal failure, and eventually death if left untreated [1] . Though initial treatment for hypertension is by administration of drugs, such treatment has limitations and at least 20% of patients [2] do not respond to medication, resulting in persistence of hypertensive conditions. As an alternative to drug therapy in treating such drug-resistant hypertension, manipulation of systemic blood pressure by stimulating carotid artery baroreceptors began to be looked at closely more than 30 years ago with the development of neck cuff apparatus, which applied sub-atmospheric pressure to the neck [3] . Localized application of such pressure distends the carotid sinus wall thereby instigating carotid baroreceptors, which are specialized stretch-sensitive nerve endings located in the sinus, to increase action potential firing rate, proportionate to which systemic blood pressure levels are regulated by a combined effort of vascular and cardiovascular effectors. The neck cuff apparatus was later improved to apply lateralized positive or negative cuff pressure [4] . As modifications were being made to mechanical devices, on a parallel track electrical stimulation of carotid baroreceptors and devices required for such stimulation were being studied and developed [5] [6] [7] [8] [9] [10] . Very recently, the efficacy of electrically activating baroreceptors was demonstrated when an electrical stimulation device induced a drop of approximately 25 mmHg mean arterial pressure (MAP) along with associated reduction in heart rate and more importantly, sustained such effects over the entire period for which the sinus was activated [11, 12] . Based on these encouraging results a miniature implantable electronic device, Rheos (CVRx, Minneapolis, MN), designed for electrical stimulation was successfully implanted in resistant hypertension patients [13, 14] . Another very interesting development was the introduction of sympathetic inhibition by renal denervation which was achieved via catheter-based ablation of the renal sympathetic nerves [15, 16] .
Despite such progress in device-based therapeutic approaches, there is still plenty of scope for development of alternate treatment methodologies. Focus of this study is on novel passive devices, designed to be implanted in the carotid sinuses of resistant hypertension patients, and the numerical methodologies used to evaluate the effects of such deployment on arterial wall biomechanics and associated fluid hemodynamics. Carotid artery models have been studied in recent years using numerical simulation techniques, such as computational fluid dynamics (CFD), to understand hemodynamic parameters in physiologic [17] [18] [19] [20] [21] and pathologic conditions [22] , whereas structural analysis of arterial wall alone has been conducted to analyze stress distribution inherent in such arteries [23] . An advanced fluid-structure interaction (FSI) methodology permits coupled analysis of fluid flow with arterial wall and is being used extensively to fully understand carotid artery dynamics [24] [25] [26] .
In this study, we push the envelope in numerical simulations by combining FSI with contact surface methodology, thereby conducting a three-way coupled dynamic interaction simulation of an endovascular device, carotid sinus in which the device is deployed, as well as the associated flow field. To the best of our knowledge, this is the first time that a fully coupled simulation of three interacting domains has been conducted. Using such augmented FSI with contact surface methodology we are able to numerically assess the ability of implant devices to stretch the carotid sinus and predict any adverse effects such a device might have on vascular hemodynamics.
Methods
Patient-specific carotid artery geometry (courtesy of Dr. David A. Steinman, University of Toronto [27] ) was provided in surface meshed format and converted to volumetric geometry using CFD preprocessing package GAMBIT (Ansys Inc, Canonsburg, PA). Lumen volume was also created using GAMBIT, with the arterial wall as volumetric reference. The geometries created consisted of lumen and artery wall as separate bodies, with the arterial wall being composed of a central common carotid artery (CCA) bifurcating into larger internal carotid artery (ICA) and smaller external carotid artery (ECA). Care was taken to ensure that the created volumes had sufficient entry length for blood flow. Discretization of the created carotid and lumen volumetric geometries and the procured device geometries was carried out using finite element analysis software package ADINA (ADINA R&D Inc., Watertown, MA) implementing a first-order four-node tetrahedral meshing scheme.
The second diminutive carotid model, representing the clinically worst case scenario of a carotid bifurcation from geometry perspective (carotid was devoid of typical sinus bulge), and two device geometries were provided by Vascular Dynamics Ltd., Herzelia, Israel. This second carotid was smaller in dimensions and more streamlined compared to the first model, with the branches of the bifurcation aligned almost parallel to each other. Whereas the first subject specific carotid was representative of an average physiologic carotid model in terms of geometry and dimensions, the smaller carotid was considered an extreme case, as it widely departed from normal physiologic geometry and was chosen to evaluate the efficacy of deploying the device in such a case, and the possible effects that the deployment might have on the flow. The two carotid models and the devices, designed for the specific carotid bifurcation geometries, are shown in Figs. 1 and 2 , respectively. The devices were designed to be in their crimped states initially. During simulations, the devices were subjected to expansion from within the sinus such that the intra-luminal deployment will induce localized increases in stretch at the sinus region populated by the baroreceptors.
Material Models. The arterial wall was modeled as a homogeneous, incompressible, nonlinear, hyperelastic material defined by isotropic Mooney-Rivlin strain-energy formulation [28] :
where I 1 and I 2 are the first and second strain invariants, C ¼ ½C ij ¼ X T X is the Cauchy-Green deformation tensor, X ¼ ½X ij ¼ ½@x i =@a j ; ðx i Þ is current position and ða j Þ is original position of the deformation tensor. Material constants in Eq. (1) were fitted with the following numerical values, from Ref. [28] :
(1) and the numerical constants were used to generate the Mooney-Rivlin material behavior curve shown in Fig. 3(b) .
Fluid domain was modeled as a Newtonian fluid with laminar flow profile and typical blood properties of q ¼ 1.035 g/cc and l ¼ 3.5 cP [29] . Fluid flow conditions were governed by both continuity and Navier-Stokes equations. The device was modeled as a linear elastic, isotropic material with stainless steel properties of E ¼ 193 GPa, ¼ 0.45, and q ¼ 8 g/cc [30] . Contact surface feature was activated to model the interaction between the device implant and the arterial wall. This feature incorporated constraint-function algorithm which enforced frictional contact and restricted interpenetration between the contacting surfaces of the two bodies. Numerical solution for contact between such interacting bodies was obtained by solving for the virtual work equation while subjecting it to prescribed specific conditions for a normal contact [31] .
Interactions between the flow domain and the encapsulating solid domain were analyzed using FSI methodology. A general Lagrangian formulation was employed for solid domain response, whereas an arbitrary-Lagrangian-Eulerian (ALE) formulation was used for the fluid domain [32] . At the FSI interfaces, displacement compatibility and traction equilibrium conditions pertaining to the two domains were imposed from which the velocity at the fluid nodes and the corresponding fluid traction exerted on the solid domain were calculated [33] .
Boundary Conditions. Physiologic pressure and velocity waveforms, corresponding to subject specific flow rates [34] , were adjusted according to the carotid model dimensions and applied as boundary conditions, as described below. For the first carotid model, time averaged flow rates in ICA and ECA branches were 3.98 ml/s and 3.04 ml/s, respectively, corresponding to which peak systolic velocities applied at the outlets of these branches were 22 cm/s and 52 cm/s. The boundary condition waveforms applied for this model are presented in Fig. 3(a) . For the second carotid, flow rates were adjusted to 2.05 ml/s and 1.48 ml/s in ICA and ECA branches such that the values would be consistent with the smaller carotid dimensions and that the wall shear stress (WSS) that develops in these branches would be in a physiologic range of 20 dyn/cm 2 and 80 dyn/cm 2 respectively. Correspondingly, the applied peak systolic velocities were 56 cm/s and 130 cm/s at the outlet of the two branches. However, as flow rates used for the second carotid were nonphysiologic, a separate case study was conducted to test the hemodynamic parameters that develop when physiologic flow rates were used, albeit applying such flow rates to a smaller than typical physiologic carotid model was likely to result in unrealistic elevated hemodynamic values. For this study, flow rates specific for the smaller carotid dimensions were doubled to 4.1 ml/s and 2.96 ml/s in the ICA and ECA, respectively, corresponding to which systolic velocities at the outlets increased to 110 cm/s and 262 cm/s, respectively. In all cases, the applied inlet CCA pressure boundary condition was not modified and ranged from 108/77 mmHg. No slip and FSI interface boundary conditions were defined for faces of the fluid domain that interact with inner surfaces of arterial wall. As the entire system was at zero stress initially, pressure and velocity waveforms were ramped up to their corresponding initial states in the cardiac cycle, within a timeframe of 1 s. Following ramping up, each simulation was carried out for two full cardiac cycles.
Solid domain boundary conditions were applied as displacement fixity for the inlet face of the CCA and axial translation for the outlet faces of the ICA and ECA. Axial stretching corresponding to 18% of the respective carotid's length was applied to induce the tension and prestress conditions inherently present in physiologic arteries. Inner surfaces of the arterial wall which come in contact with the fluid domain were marked as FSI interfaces.
The device, which is self-expanding, is initially in the crimped stressed state (inside the delivery system) and expands to a less stressed state when deployed. Expansion of the device inside the sinus was simulated by radial displacement boundary conditions, defined relative to the centroid of the device, and prescribed to the device's vertical struts (those that align with z axis). Radial Central image depicts the crimped state design of device, custom made for the extreme carotid model case, with height, 13 mm; internal diameter, 2.8 mm; and strut thickness, 0.2 mm. (Right) Image shows the model setup with the crimped device inside the sinus prior to deployment by radial expansion. The arterial wall is shown after being prestretched 18% axially along the z direction. Radial displacement boundary condition (along the x and y axes) is then applied to the vertical struts of the device (which are aligned with the z axis) such that the device would expand to 20% more than the sinus diameter of the carotid model. Similar setup and model boundary conditions are prescribed for the diminutive carotid and the second device. displacement (along x and y axes) was applied such that the expanded device diameter would be 20% more than the systolic inner diameter of sinus of the respective device's carotid model. Previous studies have indicated that oversizing the unloaded diameter of such devices by 20% more than vessel wall diameter would provide sufficient fixation force within blood vessels that will prevent migration of the device post-deployment [35, 36] . Displacement of struts was stopped once the stretching of the arterial wall was established.
All FSI simulations were performed on high-performance computing cluster composed of four quad core Xeon CPUs with a shared memory of 64 GB RAM. Grid independency of results was ensured for all simulations conducted, with simulations that produced less than 5% difference in stress and hemodynamic values for varying mesh densities chosen accordingly. The corresponding mesh densities appear in Table 1 .
Results
Biomechanical Response of Arterial Wall to Device Deployment in Carotid Sinus. Under physiologic conditions, carotid artery undergoes radial expansion in synchroneity with the pulsatility of blood flowing through it. The biomechanical response of radial wall expansion is reflected by a smooth distribution of wall stress along the arterial wall. Depending on the extent of arterial wall distension caused by blood pulsatility, wall stress magnitude varies. For the physiologic carotid model, FSI predicts wall stresses in the range of 198 kPa in carotid sinus at systole, as shown in Fig. 4 . However, an endovascular device deployed in the sinus induces further radial expansion of arterial wall thereby enhancing localized wall stresses at regions of contact. Wall stress is nonuniformly distributed and is more accentuated at such regions where the device struts interact directly with the wall. The implemented FSI with contact surface methodology predicts elevated wall stresses of up to 305 kPa at regions of deployment which corresponds to a 54% increase in localized stress at the baroreceptor region. Notably, circumferential and longitudinal arterial wall stretches are the biomechanical parameters that instigate baroreceptor activity [37] . Our simulations predict an increase of 2.5% in circumferential stretch, 7.5% in longitudinal stretch and 6% in von Mises equivalent stretch, at the sinus wall baroreceptor region caused by the deployed device.
Similar trend in elevation of wall stretch and stress values, caused by the deployed device, are observed in the diminutive model. The device induces an increase of 6% in both circumferential and longitudinal wall stretches, along with a 54% increase in von Mises equivalent stretch at sinus. Correspondingly, a 50% increase in localized wall stress is predicted at the sinus wall baroreceptors region (Fig. 5 ). Significant variations in these solid domain stress and strain results are not observed when the applied flow rates are varied.
For the specific device designs and carotid models considered in our simulations, FSI results (dynamic wall stress distribution, presented in Fig. 6 , for peak systole) indicate that wall pulsation, though attenuated, is still maintained following device deployment at the sinus region where the baroreceptors are located. Baroreceptors have been observed to adapt readily to altered static pressures applied to the sinus thereby failing to correctly regulate for such variations, whereas such adaptation to altered pressures is subdued or completely absent when the applied pressure is pulsatile [38] [39] [40] [41] [42] . Thus, the persisting attenuated wall stretch pulsation, even after device deployment, may ensure that the baroreceptors do not completely adapt to the mitigating effects that the device would have on hypertension. As further substantiation, a plot of wall stretch over cardiac cycle (Fig. 7) reveals that, at the section of carotid sinus between struts of the device, wall stretch Fig. 4 Comparative analysis of the effect of device deployment on the wall stress in the sinus region of the physiologic carotid model (top) is shown. Stress distribution is mapped for the control (left, without device) and the deployed device case (right). Stress is mapped distal to the carotid bifurcation to highlight the effects of the device in the sinus region only. The bottom images depict the overall stress distribution pattern on the inner surface of the arterial wall of the complete carotid geometry. Peak wall stress caused by device deployment at the sinus (indicated by a triangle and pointed out by an arrow) is 305 kPa, whereas the peak stress in the sinus of the carotid without the device is approximately 198 kPa. For both the control and deployed device cases the maximum stress is approximately 347 kPa.
pulsatility caused by the device is more pronounced for the physiologic carotid model, as compared to the diminutive model. A detailed analysis of time variance of wall stretch, over the entire cross section of carotid sinus including regions, which are in direct contact with the struts of the device is shown in Fig. 8 . The sections of arterial wall that are in direct contact with the device struts would experience maximum stretch and, because the device stays expanded post-deployment, those sections of the wall will have a severely attenuated pulsatility. This is reflected by the pulsatility plots of Fig. 8 . However, because the area of arterial wall between device struts is much larger than the area which is in direct contact with the struts, and the larger area experiences pulsatility post-deployment (as shown in Fig. 7 ), baroreceptor adaptation to the applied stretch stimuli will not be complete.
Predicted stretch and stress values may be influenced by several factors, such as location and orientation of the deployed device, dimensions of carotid artery and associated boundary conditions. Because the carotid models are subject specific and the corresponding boundary conditions pertain to normotensive values recorded in individuals, only influence of the deployed device orientation on the wall stresses was evaluated by varying the angle of deployment in the sinus region. As an extreme case, an 8 degree axial rotation (misalignment) of the device relative to the ICA axis, was employed in the physiologic carotid model and was observed to induce only a 0.3% drop in wall stress values at the sinus region. For the diminutive model, the deployed device was completely encapsulated by the arterial wall so that device axial misalignment was not possible. Thus, the angle of deployment orientation does not seem to have any significant influence on the wall stresses.
Hemodynamics Associated With Device Deployment. We have carefully studied the effects that device deployment may have on the carotid bifurcation hemodynamics. For the physiologic model, simulations indicate peak velocities of 22 cm/s and 52 cm/s in ICA and ECA, respectively, in both control and deployed device cases [Figs. 9(a) and 9(b), respectively]. Although deployment does not appear to influence velocity magnitude nor have any adverse effect on the ECA branch flow profile, it increases the sinus cross-section area, thereby slightly increasing the size of the characteristic recirculation zone at the sinus. However, this is expected to have nonconsequential clinical effects. For the deployed device case in the diminutive carotid model with the lower flow rates applied, peak velocity of approximately 56 cm/s and 130 cm/s is observed along the ICA and ECA branches, respectively, whereas velocity at the entrance of ECA and at the heel of the bifurcation is 74 cm/s. For this unique carotid bifurcation geometry, deployment produced a local squeezing of the ECA entrance area, decreasing it by 28% and thereby increasing the velocity of blood entering the ECA to 74 cm/s, as compared to 54 cm/s observed at the same region in the control case [Figs. 9(c) and 9(d)]. When physiologic flow rates were applied to the diminutive carotid case, ECA entrance inflow reached a peak velocity of 165 cm/s.
A combined presentation of velocity vector and wall shear stress (WSS) contour distribution (Fig. 10) indicate the formation Fig. 5 Comparative analysis of the effect of device deployment on wall stress distribution in the sinus of the diminutive carotid is shown, for the control and deployed device case. The stress distribution is depicted distal to the carotid bifurcation to highlight the effects of the device in the sinus region only. The bottom images depict the overall stress distribution pattern on the inner surface of the arterial wall of the complete carotid geometry. Peak wall stress caused by device deployment at the sinus (indicated by a triangle, location pointed out by an arrow) is 90 kPa, whereas the peak stress in the sinus of the carotid without the device is approximately 60 kPa. For the overall carotid model (bottom), peak stress occurring at the bifurcation in deployed device case is 622 kPa, whereas that in the control is 211 kPa. Reported stretch values are absolute maximum in the domains of interest. In all cases, the carotid without the device (control) has wall pulsatility. For the physiologic model with the deployed device, the carotid sinus pulsation is attenuated as shown in (b) and (c) Pulsatility for the diminutive model, shown in (e) and (f), is also attenuated compared to the control. Fig. 8 Cross sections of the carotid sinus, for the planes shown in (a) and (d ), are chosen for depicting the resulting wall stretch variation. For the physiologic model with the deployed device, the carotid sinus pulsatility is attenuated as shown in (b) and (c). Pulsatility for the diminutive model is either completely absent or extremely attenuated as shown in (e) and (f).
of typical recirculation zones in the CCA of the physiologic model, close to bifurcation and extending into the carotid sinus. These recirculation zones, only marginally affected by the device, are observed to have typical low WSS values in the range of 1-2 dyn/cm 2 . The overall sinus WSS is observed to be 2-3 dyn/ cm 2 irrespective of the presence or absence of the device. For the diminutive carotid with low flow rates, at the clinically significant region of the carotid sinus, WSS value of approximately 19 dyn/ cm 2 is observed in the control. Device deployment induces 16% reduction in sinus WSS, from 19 dyn/cm 2 to 16 dyn/cm 2 ( Fig. 11) . No recirculation zones are formed in this second carotid model, irrespective of deployment. When flow rates are increased to physiologic levels for the second model, a corresponding elevation of WSS is observed at approximately 25-30 dyn/cm 2 in the CCA and 32 dyn/cm 2 in the sinus of the deployed device case. Thus, for the first carotid model, low WSS regions concur with recirculation zones at the inner wall of ICA-CCA junction, whereas second carotid model is devoid of any apparent recirculation zones. Device deployment does not affect sinus WSS for the first model, whereas it induces 16% reduction in the smaller carotid model with low flow rates, which is expected because of the ICA cross-sectional area increase when the device is deployed.
Discussion
The objective of the study was to evaluate and quantify the effects of device deployment on the carotid sinus, such that wall stretch caused by the device might mechanically stimulate carotid baroreceptors to fire thereby reducing hypertension, and to evaluate whether such device deployment may have adverse effects on the carotid bifurcation hemodynamics. Though prior studies The plane for the velocity contour representation was specifically chosen to depict the peak velocity at the ECA entrance region, and does not reflect the centerline peak velocity in the branches. Peak systolic velocity in the ICA and the ECA of the physiologic carotid, in both the control and the deployed device case, is 22 cm/s and 52 cm/s, respectively. Device deployment in the physiologic carotid slightly increases the sinus cross section area, marginally augmenting the size of the characteristic recirculation zone in the sinus. In the second carotid, the device induces local velocity drop at the sinus as compared to the control. No flow separation is observed. The device also induces higher velocity at the entrance of the ECA (peak of 74 cm/ s) as compared to approximately 54 cm/s at the ECA entrance region of the control. focused on device-based stimulation of baroreceptors [43] [44] [45] , no one particular study had quantified the effect of such stimulation on arterial biomechanics and the associated vascular hemodynamics. To quantify the effects of such mechanical stimulation, two carotid artery geometries have been reconstructed and simulated with carotid endovascular devices deployed within their sinuses. Simulations represent evaluations conducted at a normotensive pressure of 108/77 mmHg, rather than hypertensive conditions. Such normotensive boundary conditions have been employed primarily because of nonavailability of hypertensive patient-specific values. Nevertheless, these simulations serve as a proof-of-concept and help to anticipate carotid behavior in hypertensive state as they clearly indicate the effects of the device-induced stretching in the region populated by baroreceptors. Hypertensive analyses will be discussed in future work.
Consequential results of our simulations are that the deployed devices induce localized stretching of the sinus, effectively enhancing arterial wall stresses in those regions. Using FSI simulations, the extents of wall stretch, as well as the associated wall stress that developed following device deployment, have been quantified on case by case basis. Device deployment in the physiologic carotid induces a circumferential and longitudinal wall stretch increase of 2.5% and 7.5%, and the resulting von Mises wall stress increases from 198 kPa to 305 kPa, respectively. Similarly, for the diminutive carotid case, the localized circumferential and longitudinal stretches increased by 6% each, resulting in wall stress increase from 60 kPa to 90 kPa. Such elevations of wall stretch caused by device deployment are expected to increase baroreceptor firing rate and subsequently reduce hypertension. Prior studies have shown a linear increase in baroreceptor activity for mean circumferential wall strain increase, which appears more effective than pressure or wallstress-induced changes alone (refer to Figs. 7 and 9 in Ref. [46] ). Furthermore, studies have also clearly demonstrated consequential increase in baroreceptor activity even for small strain changes (refer to Fig. 4 in Ref. [47] ), further supporting our simulation results predicting the efficacy of such devices.
Arterial biomechanical parameters are influenced by the properties of the material models of the devices. In this study, we have modeled the devices using a linear elastic material model with stainless steel properties. This is a simplification of the actual material model, as these devices are typically made of Nitinol. Our study lays the ground work for more rigorous future studies in which the complex material behavior of Nitinol would be incorporated. Nitinol-based devices are more elastic and less stiff than stainless steel, and are expected to have a marginal effect on wall pulsation. This would increase the device efficacy in preventing baroreceptor adaptation response of resetting, thereby most likely offering a more efficient treatment of hypertension.
The unique diminutive carotid model considered in our simulations represents an extreme worst case scenario from the physiologic geometry perspective, as it is devoid of the characteristic sinus bulge, and the ICA and ECA branches are in close proximity and almost parallel to each other distal to bifurcation. Such a unique carotid was primarily considered for the purpose of evaluating the device efficacy under extreme physiologic conditions that may be present in certain individuals. The effects of the device in such a worst case scenario on the ECA are anatomy specific. And, while the device deployment may induce some adverse structural or hemodynamic changes that might not otherwise be induced in more typical physiologic carotid geometries, these adverse effects in general are not considered to be critical. For the first physiologic model, simulations predict that the device induces increases in wall stretch and stress in the sinus region only (where the baroreceptors are located), and does not adversely affect the peak wall stress, which characteristically occur close to bifurcation heel (the stagnation point for the blood flow). In the diminutive model, this peak stress is adversely increased because of the close proximity of the ICA and ECA branches. The device deployment in the ICA reduces the entrance cross-sectional area for the blood entering the ECA by 28%, accelerating the local velocities and the associated wall shear stresses accordingly. The combination of the area restriction in the ECA branch, coupled with high velocity at its entrance, results in an increase of the bifurcation heel wall stress from 211 kPa (in the control) to 622 kPa. It is reiterated that such exacerbation of stress is because of the unique streamlined geometry and that such adverse effects reflect conditions that are rarely encountered in physiologic carotid arteries.
Simulation results of the physiologic carotid model are consistent with previously reported solids-only static pressurization simulation studies, as well as more advanced FSI simulations. Delfino et al. report stress at the inner walls of carotid sinus to be 220 kPa [23] , whereas Leach et al. report principal wall stress in the ICA branch to be 202 kPa [48] . These are very much in the range of our simulation results (198 kPa in sinus of the control). Consistency of fluid domain results with literature data is also noted. Low WSS is reported to be prevalent in carotid sinus of physiologic models [18, 49, 50] , and recirculation zones coinciding with such low WSS regions have been observed in similar numerical simulation studies [24] , thereby validating the predictions of our simulations. However, it is reiterated that the previous static simulations are of less predictive value due to their inherent limitations of not characterizing the hemodynamic interactions with the arterial wall, especially as pertaining to pulsatility effects and timing during the carotid flow cycle.
Conclusions
We have conducted advanced numerical simulations of the effects of deploying a novel endovascular device for treating drug-resistant hypertensive patients. We demonstrate the ability of our FSI simulations to quantify the effects of such device deployment in carotid sinuses, for evaluating its efficacy in stimulating baroreceptor firing that may result in reducing hypertension in these patients. The increase in the wall strains in the sinus regions populated by baroreceptors indicate that the device possibly will be effective in reducing hypertension with only marginal effects on the carotid bifurcation normal hemodynamics. The results appear to support the proof-of-concept of the therapeutic viability of such devices for drug-resistant hypertension treatment. Future work will further quantify device arterial interactions, as well as potential long term arterial response and wall remodeling. Further studies with varying device designs and material compositions, different patient specific geometries, and varying pathological conditions will serve to demonstrate that this numerical methodology could be further utilized for evaluation and optimization of endovascular device designs for hypertension treatment therapies on a patient specific basis. Following FSI analysis, a prototype of the device can be tested in animals with more confidence that the device will not induce adverse effects post-deployment. An animal trial evaluation coupled with extensive FSI analysis would provide convincing evidence of the device's feasibility and efficacy in resistant hypertension treatment therapy. In conclusion, FSI analysis study is envisioned to be a cost-effective methodology by which design modifications can be made and carotid's response can be evaluated without having to fabricate multiple prototypes.
